Guided Therapeutics Inc (GTHP) stock
GTHPOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$0.16−0.03 (-15.79%)
Close on Oct 19, 2026Market cap $15.45MP/E –Yield –
Guided Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Guided Therapeutics's total assets was $1.20M at Jun 30, 2026. For fiscal 2025 it was $1.32M, down 3.9% from the year before. Over ten years it grew -6.2% a year on average. The highest annual figure on record is $4.31M in fiscal 2011.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.32M | -3.9% |
| FY2024 | Dec 31, 2024 | $1.38M | -17.4% |
| FY2023 | Dec 31, 2023 | $1.67M | -50.4% |
| FY2022 | Dec 31, 2022 | $3.37M | +65.0% |
| FY2021 | Dec 31, 2021 | $2.04M | +51.1% |
| FY2020 | Dec 31, 2020 | $1.35M | +14.4% |
| FY2019 | Dec 31, 2019 | $1.18M | +400.0% |
| FY2018 | Dec 31, 2018 | $236.00K | -41.9% |
| FY2017 | Dec 31, 2017 | $406.00K | -72.8% |
| FY2016 | Dec 31, 2016 | $1.49M | -40.7% |
| FY2015 | Dec 31, 2015 | $2.52M | -17.0% |
| FY2014 | Dec 31, 2014 | $3.03M | -8.6% |
| FY2013 | Dec 31, 2013 | $3.32M | -4.7% |
| FY2012 | Dec 31, 2012 | $3.48M | -19.3% |
| FY2011 | Dec 31, 2011 | $4.31M | +10.0% |
| FY2010 | Dec 31, 2010 | $3.92M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.20M | +27.1% |
| Q1 FY2026 | Mar 31, 2026 | $1.60M | +65.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.32M | -3.9% |
| Q3 FY2025 | Sep 30, 2025 | $903.00K | -27.7% |
| Q2 FY2025 | Jun 30, 2025 | $940.00K | -24.9% |
| Q1 FY2025 | Mar 31, 2025 | $967.00K | -35.3% |
| Q4 FY2024 | Dec 31, 2024 | $1.38M | -17.4% |
| Q3 FY2024 | Sep 30, 2024 | $1.25M | -33.5% |
| Q2 FY2024 | Jun 30, 2024 | $1.25M | -46.7% |
| Q1 FY2024 | Mar 31, 2024 | $1.49M | -48.3% |
| Q4 FY2023 | Dec 31, 2023 | $1.67M | -50.4% |
| Q3 FY2023 | Sep 30, 2023 | $1.88M | -51.5% |
| Q2 FY2023 | Jun 30, 2023 | $2.35M | +56.2% |
| Q1 FY2023 | Mar 31, 2023 | $2.89M | +32.2% |
| Q4 FY2022 | Dec 31, 2022 | $3.37M | +65.0% |
| Q3 FY2022 | Sep 30, 2022 | $3.87M | +122.0% |
| Q2 FY2022 | Jun 30, 2022 | $1.50M | -27.3% |
| Q1 FY2022 | Mar 31, 2022 | $2.19M | -7.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.04M | +51.1% |
| Q3 FY2021 | Sep 30, 2021 | $1.74M | +34.2% |
| Q2 FY2021 | Jun 30, 2021 | $2.07M | +119.4% |
| Q1 FY2021 | Mar 31, 2021 | $2.36M | +548.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.35M | +14.4% |
| Q3 FY2020 | Sep 30, 2020 | $1.30M | +283.5% |
| Q2 FY2020 | Jun 30, 2020 | $942.00K | +262.3% |
| Q1 FY2020 | Mar 31, 2020 | $364.00K | -9.9% |
| Q4 FY2019 | Dec 31, 2019 | $1.18M | +400.0% |
| Q3 FY2019 | Sep 30, 2019 | $339.00K | -31.0% |
| Q2 FY2019 | Jun 30, 2019 | $260.00K | -37.8% |
| Q1 FY2019 | Mar 31, 2019 | $404.00K | -23.3% |
| Q4 FY2018 | Dec 31, 2018 | $236.00K | -41.9% |
| Q3 FY2018 | Sep 30, 2018 | $491.00K | -45.7% |
| Q2 FY2018 | Jun 30, 2018 | $418.00K | -72.3% |
| Q1 FY2018 | Mar 31, 2018 | $527.00K | -64.7% |
| Q4 FY2017 | Dec 31, 2017 | $406.00K | -72.8% |
| Q3 FY2017 | Sep 30, 2017 | $905.00K | -56.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.49M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.49M | – |
| Q3 FY2016 | Sep 30, 2016 | $2.06M | – |
See a number that looks wrong?